| Name | Title | Contact Details |
|---|
Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations.
Access to Therapy is a Encino, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Our story begins in 2005, with a healthcare professional, Dr. Kathleen Myers. She was hired to help open a new, paperless hospital using multiple EMRs and CPOE. A dedicated emergency medicine physician, she knew that every minute counted and worried that “going paperless” would take valuable time away from patients — which was unacceptable. She challenged herself to find a solution. Her answer was a scribe program. She championed development of this for her emergency department, and scribes quickly became an indispensable part of her practice of medicine. So much so, that Dr. Myers sought the support of like-minded individuals with an entrepreneurial spirit to bring these services to other physicians across the country. This is where the company took root. In 2011, Dr. Myers founded Essia Health (formerly Scribes STAT, Inc.) in Portland, Oregon. As a physician, Dr. Myers’ deep expertise helped her to find the pain points of medical practice —where Essia could be most impactful: premium scribe services and EMR support for healthcare providers. In 2013 she was joined by a leadership team of industry experts to carry out Essia’s mission. The response was tremendous. Today, Essia Health has more than 600 employees partnering with institutions nationwide to empower physicians to focus on the practice of medicine. Recognized as a premier provider of scribe services and EMR support, Essia has won multiple awards for excellence in client satisfaction. We have partnered with multi-state hospital networks, specialty clinics, and multispecialty clinics, and we have managed more than 200 successful EMR Go-Lives. Technological change is important. People are most important. Which is why Essia is proud of a heritage of best-in-class service to help our customers navigate this change effectively. We do this by anticipating and resolving unique challenges with quick, innovative solutions that make technology work for you — and not the other way around! There’s nothing better than working with people who truly speak your language.
Stilla Technologies is a leading global biotechnology company that focuses on accelerating development of next-generation genetic testing by providing researchers and clinicians with a flexible Digital PCR solution for high-resolution genetic analysis and assay development. Stilla`s next-generation Multiplex Crystal Digital PCR™ technology employs cutting-edge microfluidic innovations and integrates the entire dPCR process on a single chip. The naica® system is highly sensitive, fast, and features an easy workflow, higher levels of multiplexing, and intuitive software. Stilla developed the world`s first 6-color Digital PCR Platform, providing High Multiplexing and Sensitivity for Advancing Cancer & Liquid Biopsy Studies, Cell & Gene Therapies, Infectious Disease & COVID-19 Research, and Wastewater and Environmental Testing and many more applications. Stilla aims to make Digital PCR a lab commodity in all life sciences areas including research, therapeutics, and the omics.
Integrated Health Plan Inc is a Saint Petersburg, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.